Data as of Jun 19
| -0.0155 / -2.69%|
The 7 analysts offering 12-month price forecasts for Anthera Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 3.61 and a low estimate of 0.50. The median estimate represents a +256.82% increase from the last price of 0.56.
The current consensus among 8 polled investment analysts is to Buy stock in Anthera Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.